Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009-2016

As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. We combined individual-level data on patients with pulmonary MDR-TB published during 2009-2016 from 25 countries. We compared patients receiving each of the injectable drug...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases Jg. 73; H. 11; S. e3929
Hauptverfasser:	Cegielski, J Peter, Chan, Pei-Chun, Lan, Zhiyi, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 06.12.2021
Schlagworte:	Aminoglycosides - therapeutic use Antitubercular Agents - pharmacology Capreomycin - pharmacology Capreomycin - therapeutic use Humans Microbial Sensitivity Tests Mycobacterium tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy meta-analysis capreomycin treatment aminoglycosides multidrug-resistant tuberculosis
ISSN:	1537-6591, 1537-6591
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!